Beta Drugs Ltd

- Pantomath Capital Advisors Pvt Ltd

Public issue of 22,96,000 equity shares of face value of Rs. 10/- each (equity shares) of Beta Drugs Limited (the company Or the issuer) for cash at a price of Rs. 85/- per equity share, including a share premium of Rs. 75/- per equity share (the issue price), aggregating Rs. 19.52 crores (the issue), of which 1,29,600 equity shares of face value of Rs. 10/- each for Cash at a price of Rs. 85/- per equity share, aggregating Rs. 1.10 crores will be reserved for subscription by the market Maker to the issue (the market maker reservation portion). The issue less market maker reservation portion i.e. Issue of 21,66,400 equity shares of face value of Rs. 10 each for cash at a price of Rs. 85/- per equity share, aggregatingRs. 18.42 crores is hereinafter referred to as the net issue. The issue and the net issue will constitute 26.54% and 25.05% Respectively of the fully diluted post issue paid up equity share capital of the company.The face value of the equity shares is Rs. 10 each and the issue price of Rs. 85 is 8.5 times of the face value of the Equity shares.

  • Issue

    • Opens On29 Sep 2017
    • Closes On04 Oct 2017
  • Money Payable On

    • Application85
    • Allotment0
  • Project Cost (Cr.)19.52
  • Post Issue Equity Share Capital (Cr.)8.65
  • Issue Price (D)85

Further Multiples of: 1600

Projects

  • Promoted By
    • Listing At - NSE - SME
    • Registrar to the Issue - Link Intime India Pvt Ltd

    Village Nandpur Baddi

    Himachal Pradesh- 174101

    Phone - 91-1795-236196

    Fax -

    Email - info@betadrugslimited.com

    Website - www.betadrugslimited.com

    Ready to invest with us?

    Share your Name and Mobile Number with us and get started

    • +91|
    scrollToTop